Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Nov 11;8(15):24303–24313. doi: 10.18632/oncotarget.13286

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © 2017 Chebouti et al.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC-BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PMC Copyright notice

This analysis refers to the prognostic relevance of ERCC1-transcripts alone, irrespectively of the Adnatest transcript markers EpCAM, MUC-1 or CA-125. The Kaplan-Meier plots show A. progression-free survival and B. overall survival of patients with ERCC1-positivity after platinum-based chemotherapy (bottom curves) in comparison to patients with non-detectable ERCC1-transcripts (top curves). Moreover, Kaplan-Meier plots show C. progression-free survival and D. overall survival of patients with persistent positivity for ERCC1-transcripts (ERCC1⁺ pos-pos, bottom curves) in comparison to all other dynamic subgroups together (ERCC1⁺ pos-neg / neg-pos / neg-neg, top curves).